Bill Texts: NJ A116 | 2020-2021 | Regular Session

Bill Title: Requires physician to offer to test patient for dihydropyrimidine dehydrogenase deficiency prior to patient undergoing chemotherapy.

Spectrum: Partisan Bill (Republican 2-0)

Status: (Introduced - Dead) 2020-01-14 - Introduced, Referred to Assembly Health Committee [A116 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2020-01-14HTML/TextLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for New Jersey A116

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for New Jersey A116 currently on file.

Social Comments on NJ A116

feedback